Работы, цитирующие эту работу

Работ: 4

Работа: NLRP3 inflammasome in cancer and metabolic diseases

1. NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy

   Hamza Abu Owida, Ahmed Abed, Farag M. A. Altalbawy +7

   Обзорная статьяInflammasome and immune disordersNaunyn-Schmiedeberg s Archives of Pharmacology2025Цитирований: 1

   ABIABI:AkademIndex/openalex/2025.review-article.000073

2. Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo

   Jinqian Mao, Yunfei Chen, Qiushuo Zong +10

   СтатьяPhytochemistry and Bioactivity StudiesFrontiers in Immunology2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.article.000748

3. Non-coding RNAs as a Critical Player in the Regulation of Inflammasome in Inflammatory Bowel Diseases; Emphasize on lncRNAs

   H. Abed, Enwa Felix Oghenemaro, Aziz Kubaev +7

   Обзорная статьяCancer-related molecular mechanisms researchCell Biochemistry and Biophysics2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.review-article.000134

4. Treatment of Parkinson’s Disease with an Anti-Inflammasome NLRP3 Inhibitor Derived from a Natural Product

   Wenqian Li, Jiu‐liang Zhang, Qiang Chen +13

   СтатьяInflammasome and immune disordersACS Pharmacology & Translational Science2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.article.009063